2019 Choroidal Neovascularization Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025
The global clinical trial report- “2019 Choroidal Neovascularization Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Choroidal Neovascularization. It presents in-depth analysis of Choroidal Neovascularization clinical trials across markets and companies. The research work is for providing complete understanding into trends in Choroidal Neovascularization.
The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.
It also segments the Choroidal Neovascularization clinical trials by-
The research work is prepared through extensive and continuous research on Choroidal Neovascularization trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.
Report Scope and Coverage:
The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.
It also segments the Choroidal Neovascularization clinical trials by-
- Current Trial Status
- Type of the trial
- Sponsor Type
- Enrollment Trends
- Region
- Countries
- Trial Phase
The research work is prepared through extensive and continuous research on Choroidal Neovascularization trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.
Report Scope and Coverage:
- All major trials from 2010 to 2019 and planned trials are included in the report scope.
- Drug candidates currently being researched for administering Choroidal Neovascularization patients are identified
- The report includes panorama of Choroidal Neovascularization clinical trials across the globe
- Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
- Companies and universities focusing on Choroidal Neovascularization clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
- Average Enrollment number, insights into enrollment trends, company wise enrollment are included
- Both interventional and observational studies are analyzed
- News and latest developments for the past one year are presented in the report
1. TABLE OF CONTENTS
1.1 List of Figures
1.2 List of Tables
2. EXECUTIVE SUMMARY
2.1 Choroidal Neovascularization Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Choroidal Neovascularization Clinical Trials by Region
2.2.2 Average Enrollment of Choroidal Neovascularization Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Choroidal Neovascularization Treatment, 2019
3. REGION WISE CHOROIDAL NEOVASCULARIZATION CLINICAL TRIALS
3.1 Asia Pacific Choroidal Neovascularization Clinical Trials by Country
3.2 Europe Choroidal Neovascularization Clinical Trials by Country
3.3 North America Choroidal Neovascularization Clinical Trials by Country
3.4 Middle East and Africa Choroidal Neovascularization Clinical Trials by Country
3.5 South and Central America Choroidal Neovascularization Clinical Trials by Country
4. CHOROIDAL NEOVASCULARIZATION CLINICAL TRIAL TRENDS
4.1 Start Year wise Choroidal Neovascularization Clinical Trials
4.2 Phase wise Choroidal Neovascularization Clinical Trials
4.3 Trial Status wise Choroidal Neovascularization Clinical Trials
4.4 Trial Type wise Choroidal Neovascularization Clinical Trials
5. CHOROIDAL NEOVASCULARIZATION AVERAGE ENROLLMENT TRENDS
5.1 Average Enrollment in Choroidal Neovascularization Trials by Year
5.2 Average Enrollment in Choroidal Neovascularization Trials by Phase
5.3 Average Enrollment in Choroidal Neovascularization Trials by Status
5.4 Average Enrollment in Choroidal Neovascularization Trials by Type of Trial
6. COMPANIES PARTICIPATING IN CHOROIDAL NEOVASCULARIZATION CLINICAL TRIALS
6.1 Choroidal Neovascularization Trials by Sponsor Type
6.2 Choroidal Neovascularization Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors
7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS
7.1 Choroidal Neovascularization Trials- Phase
7.2 Choroidal Neovascularization Trials- Phase
7.3 Choroidal Neovascularization Trials- Phase
7.4 Choroidal Neovascularization Trials- Phase
8. APPENDIX
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise
1.1 List of Figures
1.2 List of Tables
2. EXECUTIVE SUMMARY
2.1 Choroidal Neovascularization Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Choroidal Neovascularization Clinical Trials by Region
2.2.2 Average Enrollment of Choroidal Neovascularization Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Choroidal Neovascularization Treatment, 2019
3. REGION WISE CHOROIDAL NEOVASCULARIZATION CLINICAL TRIALS
3.1 Asia Pacific Choroidal Neovascularization Clinical Trials by Country
3.2 Europe Choroidal Neovascularization Clinical Trials by Country
3.3 North America Choroidal Neovascularization Clinical Trials by Country
3.4 Middle East and Africa Choroidal Neovascularization Clinical Trials by Country
3.5 South and Central America Choroidal Neovascularization Clinical Trials by Country
4. CHOROIDAL NEOVASCULARIZATION CLINICAL TRIAL TRENDS
4.1 Start Year wise Choroidal Neovascularization Clinical Trials
4.2 Phase wise Choroidal Neovascularization Clinical Trials
4.3 Trial Status wise Choroidal Neovascularization Clinical Trials
4.4 Trial Type wise Choroidal Neovascularization Clinical Trials
5. CHOROIDAL NEOVASCULARIZATION AVERAGE ENROLLMENT TRENDS
5.1 Average Enrollment in Choroidal Neovascularization Trials by Year
5.2 Average Enrollment in Choroidal Neovascularization Trials by Phase
5.3 Average Enrollment in Choroidal Neovascularization Trials by Status
5.4 Average Enrollment in Choroidal Neovascularization Trials by Type of Trial
6. COMPANIES PARTICIPATING IN CHOROIDAL NEOVASCULARIZATION CLINICAL TRIALS
6.1 Choroidal Neovascularization Trials by Sponsor Type
6.2 Choroidal Neovascularization Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors
7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS
7.1 Choroidal Neovascularization Trials- Phase
7.2 Choroidal Neovascularization Trials- Phase
7.3 Choroidal Neovascularization Trials- Phase
7.4 Choroidal Neovascularization Trials- Phase
8. APPENDIX
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise
LIST OF FIGURES
Figure 1: Choroidal Neovascularization Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Choroidal Neovascularization Clinical Trials and Enrolment
Figure 5: Europe – Country wise Choroidal Neovascularization Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Choroidal Neovascularization Clinical Trials and Enrolment
Figure 7: North America – Country wise Choroidal Neovascularization Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Choroidal Neovascularization Clinical Trials and Enrolment
Figure 9: Choroidal Neovascularization Clinical Trials by Phase
Figure 10: Choroidal Neovascularization Clinical Trials by Trial Status
Figure 11: Choroidal Neovascularization Clinical Trials by Type
Figure 12: Choroidal Neovascularization Clinical Trials by Sponsor Type
Figure 13: Choroidal Neovascularization Clinical Trials by Leading Sponsors
Figure 14: Choroidal Neovascularization Average Enrollment by Phase
Figure 15: Choroidal Neovascularization Average Enrollment by Trial Status
Figure 16: Choroidal Neovascularization Average Enrollment by Type
Figure 17: Choroidal Neovascularization- Average Enrolment by Type of Sponsors
Figure 18: Choroidal Neovascularization- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology
Figure 1: Choroidal Neovascularization Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Choroidal Neovascularization Clinical Trials and Enrolment
Figure 5: Europe – Country wise Choroidal Neovascularization Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Choroidal Neovascularization Clinical Trials and Enrolment
Figure 7: North America – Country wise Choroidal Neovascularization Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Choroidal Neovascularization Clinical Trials and Enrolment
Figure 9: Choroidal Neovascularization Clinical Trials by Phase
Figure 10: Choroidal Neovascularization Clinical Trials by Trial Status
Figure 11: Choroidal Neovascularization Clinical Trials by Type
Figure 12: Choroidal Neovascularization Clinical Trials by Sponsor Type
Figure 13: Choroidal Neovascularization Clinical Trials by Leading Sponsors
Figure 14: Choroidal Neovascularization Average Enrollment by Phase
Figure 15: Choroidal Neovascularization Average Enrollment by Trial Status
Figure 16: Choroidal Neovascularization Average Enrollment by Type
Figure 17: Choroidal Neovascularization- Average Enrolment by Type of Sponsors
Figure 18: Choroidal Neovascularization- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology
LIST OF TABLES
Table 1: Choroidal Neovascularization Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Choroidal Neovascularization Clinical Trials and Enrolment
Table 5: Europe – Country wise Choroidal Neovascularization Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Choroidal Neovascularization Clinical Trials and Enrolment
Table 7: North America – Country wise Choroidal Neovascularization Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Choroidal Neovascularization Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Choroidal Neovascularization Average Enrollment by Phase
Table 15: Choroidal Neovascularization Average Enrollment by Trial Status
Table 16: Choroidal Neovascularization Average Enrollment by Type
Table 17: Choroidal Neovascularization- Average Enrolment by Type of Sponsors
Table 18: Choroidal Neovascularization- Enrolment by Leading Sponsors
Table 1: Choroidal Neovascularization Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Choroidal Neovascularization Clinical Trials and Enrolment
Table 5: Europe – Country wise Choroidal Neovascularization Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Choroidal Neovascularization Clinical Trials and Enrolment
Table 7: North America – Country wise Choroidal Neovascularization Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Choroidal Neovascularization Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Choroidal Neovascularization Average Enrollment by Phase
Table 15: Choroidal Neovascularization Average Enrollment by Trial Status
Table 16: Choroidal Neovascularization Average Enrollment by Type
Table 17: Choroidal Neovascularization- Average Enrolment by Type of Sponsors
Table 18: Choroidal Neovascularization- Enrolment by Leading Sponsors
